CARGO Therapeutics, — Company Overview, News & Financial Data
Cargo Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for hematologic malignancies like AML and MDS.
CARGO Therapeutics,
Company profile
About CARGO Therapeutics,
Cargo Therapeutics (NASDAQ:CRGX) is a clinical-stage biopharmaceutical company developing innovative medicines for hematologic malignancies, which are cancers of the blood and blood-forming tissues. Their lead candidate, rocatribor, is a targeted small molecule inhibitor currently in Phase 2 clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Cargo Therapeutics aims to leverage its scientific expertise and collaborative partnerships to bring life-changing therapies to patients with these challenging diseases.
Snapshot
2019Year founded
118Employees
California, United StatesHead office
Loading Map...
Global footprint
Operations
All Locations
United States
Products and/or services of CARGO Therapeutics,
- Rocatribor: A targeted small molecule inhibitor currently in Phase 2 clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
- CAR-T cell therapy: A personalized cellular therapy approach that involves engineering a patient's T cells to recognize and attack cancer cells.
- CAR-NK cell therapy: Another form of cellular therapy using natural killer (NK) cells, which have the innate ability to recognize and kill cancer cells.
- Bispecific T cell engagers (BiTEs): A type of immunotherapy that uses molecules to link T cells to cancer cells, triggering the immune system to destroy the cancer cells.
- TCR-T cell therapy: A cellular therapy approach that uses T cells engineered with a specific T cell receptor (TCR) to recognize and target cancer cells.
- Gene editing therapies: A new frontier in cancer treatment that uses technologies like CRISPR to modify genes and potentially cure cancer.
CARGO Therapeutics, executive team
- Mr. Anup RadhakrishnanInterim CEO, CFO, Secretary, COO & Director
- Dr. Crystal L. Mackall M.D.Co-Founder & Scientific Advisory Board Chair
- Dr. Robbie Majzner M.D.Co-Founder & Scientific Advisory Board Member
- Ms. Nancy Goodman J.D.Founder
- Dr. Louai Labanieh Ph.D.Founder
- Ms. Halley E. Gilbert Esq., J.D.Chief Legal Officer
- Ms. Kari E. LeetchChief People Officer
GET YOUR GRAFA EDGE NOW
Sign up free to follow this company
We'll switch on a 30-day Edge trial as a welcome gift